Proposals to streamline regulatory approval of new drugs would bode well for biotech companies like Amgen in Thousand Oaks. If President-elect Donald Trump reduces corporate income taxes as he proposed, it could bring an infusion of capital that could be a game changer for the tri-county biotech sector. Trump’s proposal to reduce corporate income taxes…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
